Santiago Costas Ramon

Santiago Costas Ramon

Auto-generated profile, based on publicly available information

Santiago Costas Ramon

Institute for Immunology, Faculty of Medicine, TU Dresden, Dresden, Germany

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TSTina Schumann
Tina Schumann
SRSantiago Costas Ramon
Santiago Costas Ramon
NSNadja Schubert
Nadja Schubert
MMMohamad Aref Mayo
Mohamad Aref Mayo
MHMelanie Hega
Melanie Hega
RBRayk Behrendt
Rayk Behrendt
Defects in nucleic acid metabolizing enzymes can lead to spontaneous but selective activation of either cGAS/STING or RIG-like receptor (RLR) signaling, causing type I interferon–driven inflammatory diseases. In these pathophysiological conditions, activation of the DNA sensor cGAS and IFN production are linked to spontaneous DNA damage. Physiological, or tonic, IFN signaling on the other hand is essential to functionally prime nucleic acid sensing pathways. Here, we show that low-level chronic DNA damage in mice lacking the Aicardi-Goutières syndrome gene SAMHD1 reduced tumor-free survival when crossed to a p53-deficient, but not to a DNA mismatch repair-deficient background. Increased DNA damage did not result in higher levels of type I interferon. Instead, we found that the chronic interferon response in SAMHD1-deficient mice was driven by the MDA5/MAVS pathway but required functional priming through the cGAS/STING pathway. Our work positions cGAS/STING upstream of tonic IFN signaling in Samhd1-deficient mice and highlights an important role of the pathway in physiological and pathophysiological innate immune priming.

19 June 2023 in Cancer Research
Verified
Journal Article
Closed access
PDF file
NDNicole Dressel
Nicole Dressel
LNLoreen Natusch
Loreen Natusch
CMClara M. Munz
Clara M. Munz
SRSantiago Costas Ramon
Santiago Costas Ramon
MMMina Nabil Farid Morcos
Mina Nabil Farid Morcos
AGAlexander Gerbaulet
Alexander Gerbaulet
Genome damage is a main driver of malignant transformation, but it also induces aberrant inflammation via the cGAS/STING DNA-sensing pathway. Activation of cGAS/STING can trigger cell death and senescence, thereby potentially eliminating genome-damaged cells and preventing against malignant transformation. Here, we report that defective ribonucleotide excision repair (RER) in the hematopoietic system caused genome instability with concomitant activation of the cGAS/STING axis and compromised hematopoietic stem cell function, ultimately resulting in leukemogenesis. Additional inactivation of cGAS, STING, or type I IFN signaling, however, had no detectable effect on blood cell generation and leukemia development in RER-deficient hematopoietic cells. In wild-type mice, hematopoiesis under steady-state conditions and in response to genome damage was not affected by loss of cGAS. Together, these data challenge a role of the cGAS/STING pathway in protecting the hematopoietic system against DNA damage and leukemic transformation. Significance: Loss of cGAS/STING signaling does not impact DNA damage–driven leukemogenesis or alter steady-state, perturbed or malignant hematopoiesis, indicating that the cGAS/STING axis is not a crucial antioncogenic mechanism in the hematopoietic system. See related commentary by Zierhut, p. 2807

24 November 2025
Verified
Other
Open access
NDNicole Dressel
Nicole Dressel
LNLoreen Natusch
Loreen Natusch
CMClara M. Munz
Clara M. Munz
SRSantiago Costas Ramon
Santiago Costas Ramon
MMMina Nabil Farid Morcos
Mina Nabil Farid Morcos
AGAlexander Gerbaulet
Alexander Gerbaulet
List of antibodies used in the study

16 September 2024
Verified
Other
Open access
NDNicole Dressel
Nicole Dressel
LNLoreen Natusch
Loreen Natusch
CMClara M. Munz
Clara M. Munz
SRSantiago Costas Ramon
Santiago Costas Ramon
MMMina Nabil Farid Morcos
Mina Nabil Farid Morcos
AGAlexander Gerbaulet
Alexander Gerbaulet
Table S2 from Activation of the cGAS/STING axis in genome-damaged hematopoietic cells does not impact blood cell formation or leukemogenesis

16 September 2024
Verified
Other
Open access
NDNicole Dressel
Nicole Dressel
LNLoreen Natusch
Loreen Natusch
CMClara M. Munz
Clara M. Munz
SRSantiago Costas Ramon
Santiago Costas Ramon
MMMina Nabil Farid Morcos
Mina Nabil Farid Morcos
AGAlexander Gerbaulet
Alexander Gerbaulet
List of antibodies used in the study

16 September 2024
Verified
Other
Open access
NDNicole Dressel
Nicole Dressel
LNLoreen Natusch
Loreen Natusch
CMClara M. Munz
Clara M. Munz
SRSantiago Costas Ramon
Santiago Costas Ramon
MMMina Nabil Farid Morcos
Mina Nabil Farid Morcos
AGAlexander Gerbaulet
Alexander Gerbaulet
Genome damage is a main driver of malignant transformation, but it also induces aberrant inflammation via the cGAS/STING DNA sensing pathway. Activation of cGAS/STING can trigger cell death and senescence, thereby potentially eliminating genome-damaged cells and preventing against malignant transformation. Here, we report that defective ribonucleotide excision repair (RER) in the hematopoietic system caused genome instability with concomitant activation of the cGAS/STING axis and compromised hematopoietic stem cell function, ultimately resulting in leukemogenesis. Additional inactivation of cGAS, STING, or type I IFN signaling, however, had no detectable effect on blood cell generation and leukemia development in RER-deficient hematopoietic cells. In wild-type mice, hematopoiesis under steady-state conditions and in response to genome damage was not affected by loss of cGAS. Together, this data challenges a role of the cGAS/STING pathway in protecting the hematopoietic system against DNA damage and leukemic transformation.